BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6985640)

  • 1. Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.
    Manjula BN; Fischetti VA
    J Immunol; 1980 Jan; 124(1):261-7. PubMed ID: 6985640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.
    Beachey EH; Stollerman GH; Chiang EY; Chiang TM; Seyer JM; Kang AH
    J Exp Med; 1977 Jun; 145(6):1469-83. PubMed ID: 325168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein.
    Wang B; Schlievert PM; Gaber AO; Kotb M
    J Immunol; 1993 Aug; 151(3):1419-29. PubMed ID: 8335938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
    Thakur A; Singhal S; Prakash K
    J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical properties of streptococcal M protein purified by isoelectric focusing.
    Cunningham M; Beachey EH
    J Immunol; 1975 Oct; 115(4):1002-6. PubMed ID: 1100717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci.
    Manjula BN; Acharya AS; Mische SM; Fairwell T; Fischetti VA
    J Biol Chem; 1984 Mar; 259(6):3686-93. PubMed ID: 6368549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.
    Watanabe-Ohnishi R; Aelion J; LeGros L; Tomai MA; Sokurenko EV; Newton D; Takahara J; Irino S; Rashed S; Kotb M
    J Immunol; 1994 Feb; 152(4):2066-73. PubMed ID: 8120408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the immunodeterminants of the complete streptococcal M6 protein molecule. Identification of an immunodominant region.
    Fischetti VA; Windels M
    J Immunol; 1988 Nov; 141(10):3592-9. PubMed ID: 2460540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a putative fimbrial protein/receptor of Porphyromonas gingivalis.
    Dashper SG; O'Brien-Simpson NM; Bhogal PS; Franzmann AD; Reynolds EC
    Aust Dent J; 1998 Apr; 43(2):99-104. PubMed ID: 9612983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunobiology of M-proteins of Streptococcus pyogenes. I. Isolation and purification of M-proteins from group A streptococci (Streptococcus pyogenes) type 1].
    Kühnemund O; Köhler W
    Allerg Immunol (Leipz); 1976; 22(2):171-8. PubMed ID: 136885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
    Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
    Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of the type specific M protein from toxic cross reactive antigens of group A streptococci.
    Beachey EH; Chiang EY; Seyer JM; Kang AH; Chiang TM; Stollerman GH
    Trans Assoc Am Physicians; 1977; 90():390-400. PubMed ID: 347677
    [No Abstract]   [Full Text] [Related]  

  • 18. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes.
    Sargent SJ; Beachey EH; Corbett CE; Dale JB
    J Immunol; 1987 Aug; 139(4):1285-90. PubMed ID: 2440952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.